Cellulase/hyoscyamine/pancrelipase/phenyltoloxamine Interactions
There are 370 drugs known to interact with cellulase/hyoscyamine/pancrelipase/phenyltoloxamine, along with 24 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 10 are major, 342 are moderate, and 18 are minor.
- View all 370 medications that may interact with cellulase/hyoscyamine/pancrelipase/phenyltoloxamine
- View cellulase/hyoscyamine/pancrelipase/phenyltoloxamine alcohol/food interactions (2)
- View cellulase/hyoscyamine/pancrelipase/phenyltoloxamine disease interactions (24)
Most frequently checked interactions
View interaction reports for cellulase / hyoscyamine / pancrelipase / phenyltoloxamine and the medicines listed below.
- Creon (pancrelipase)
- Creon (pancrelipase)
- Nicotinamide ZCF (multivitamin with minerals)
- Nicotinamide ZCF (multivitamin with minerals)
- Omega-3 (omega-3 polyunsaturated fatty acids)
- Omega-3 (omega-3 polyunsaturated fatty acids)
- Quercetin (bioflavonoids)
- Quercetin (bioflavonoids)
- Redux (dexfenfluramine)
- Redux (dexfenfluramine)
- Sotalol Hydrochloride AF (sotalol)
- Sotalol Hydrochloride AF (sotalol)
- Vitamin B1 (thiamine)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
- Vitamin K (phytonadione)
Cellulase/hyoscyamine/pancrelipase/phenyltoloxamine alcohol/food interactions
There are 2 alcohol/food interactions with cellulase / hyoscyamine / pancrelipase / phenyltoloxamine.
Cellulase/hyoscyamine/pancrelipase/phenyltoloxamine disease interactions
There are 24 disease interactions with cellulase / hyoscyamine / pancrelipase / phenyltoloxamine which include:
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- reactive airway diseases
- myasthenia gravis
- infectious diarrhea
- cardiac disease
- tachycardia
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- coronary artery disease
- gastric ulcer
- gastroesophageal reflux
- ulcerative colitis
- liver disease
- renal failure
- hyperuricemia
- hypertension
- hyperthyroidism
- diarrhea
- fever
Report options
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Creon
Creon (pancrelipase) contains digestive enzymes and is used to improve food digestion in people who ...
Hi-Vegi-Lip
Hi-Vegi-Lip is used for chronic pancreatitis, cystic fibrosis, pancreatitis
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.